LYB — Claude Opus 4.8

I'll research LyondellBasell (LYB) before writing the preview. Let me gather recent earnings, filings, and news.This is a dynamic scenario — a Middle East conflict has reshaped petrochemical markets. Let me get the Q1 2026 release numbers, recent news, and stock price action.Let me get the Q1 2026 earnings release for the actual reported numbers and Q2 operating-rate guidance.# LyondellBasell (LYB) — Q2 2026 Earnings Preview

Report expected before market open, Friday July 31, 2026

Why this print matters more than usual

This is the quarter investors have been waiting for. A Middle East conflict (Iran / Strait of Hormuz disruptions) erupted around early March 2026 and, in LYB's own framing, "transformed the global cost curve for petrochemicals." Q1 2026 (reported May 1) only captured the tail end of that shock — the March price spike. Q2 2026 is the first full quarter that reflects the war-driven tightening, including the ~$0.50/lb of cumulative polyethylene price increases management said it was pushing through in April and May.

In short: after roughly three years of a brutal petrochemical down-cycle, this report is the first real read on how much upside LYB's cost-advantaged US and European assets can capture in a suddenly supply-short world — and, just as importantly, whether the market believes it's durable.

Where the stock sits going in

Date	LYB	Note
Jan 2, 2026	$44.39	Trough / cycle low sentiment
Mar 30, 2026	$82.38	Peak — full "war premium" euphoria
Jun 29, 2026	$53.62	Gave back most of the rally
Jul 30, 2026	~$60.46	Recovering into the print

The stock is up ~36% YTD but sits ~27% below its late-March peak. That round-trip tells the whole story: the market front-ran a super-cycle in Q1, then de-rated on fears that (a) the conflict resolves and prices reverse, and (b) high prices trigger demand destruction. Peers Dow (DOW) and Westlake (WLK) traced similar arcs. So the setup is unusual — numbers should be strong, but expectations have already partially reset lower, making guidance and management's tone on durability arguably more important than the headline beat/miss.

The numbers: expect a sharp sequential ramp

Recent trajectory of EBITDA excluding identified items: - Q4 2025: $417M (near cycle bottom) - Q1 2026: $615M, EPS $0.49 (EBITDA +~50% q/q, driven by the March inflection) - Q2 2026: Should step up meaningfully again given a full quarter of price increases and higher operating rates.

For reference on both the downside base and the bull-case ceiling: - Q2 2025 (year-ago, pre-war): EBITDA ex-items $715M, EPS ex-items $0.62 - Q2 2024: EBITDA $1.33B — a reminder of what a healthier environment looks like - The 2021 super-cycle peak: O&P-Americas alone earned $1.5–1.6B of EBITDA per quarter. Management was explicitly asked whether that's repeatable and did not rule it out, noting PE prices were only ~$0.10–0.15/lb below 2021 levels before the latest increases.

What to watch by segment (vs. Q1 2026 and management's Q2 guide):

O&P Americas ($327M in Q1): The single biggest swing factor. Management guided to ~90% utilization, cracker rates near 95%, April order books ~20% above pre-war levels, and cumulative $0.50/lb PE price hikes plus $0.10/lb/month PP spread gains. This is where a blowout would come from. Watch how much of the announced increases actually settled.
O&P EAI (Europe/Asia) (–$6M in Q1): Guided to ~80% operating rates and improving margins as Middle East/China imports recede. Crucially, the sale of four European assets closed early in Q2 — removing a small/negative-EBITDA business and ~€400M/yr of fixed costs and ~€110M/yr of capex. Expect a cleaner, structurally higher-margin European footprint (plus a potential €100M earn-out).
I&D ($224M in Q1): Guided down to ~75% operating rates because the Bayport PO/TBA outage (~$25M/week hit) runs until end of Q2. Offsets: oxyfuels margin recovery and methanol pricing that doubled (~$300→$600/ton). This segment may look soft this quarter but sets up for a strong Q3 once Bayport restarts (management targets 95–100% rates thereafter).
APS ($58M in Q1): Volumes surprisingly strong, but margins pressured by contractual pricing lags as raw-material costs rose — the near-term drag here is timing, not demand.
Technology ($18M in Q1): Guided "only slightly lower than Q4 2025." Licensing demand is at a ~15-year low as Chinese capacity additions stall — a longer-term structural watch item, not a Q2 mover.

The central debate: is the "war premium" durable?

This is the question that will dominate the call. Management's stance (which differs from third-party consultants who model a sharp H2 fade in PE prices): - LYB argues the disruption is measured in "multiple quarters, not months" — physical asset damage, rerouted logistics (~9–12 months to normalize), and a structurally steeper cost curve that persists even after a ceasefire, because a geopolitical risk premium and the loss of sanctioned-crude discounts don't reverse quickly. - The bull case on polypropylene ("the sleeping giant"): ~70% of global PP supply is impacted directly/indirectly via the Strait of Hormuz and idled Asian PDH units; PP prices are still ~$0.60/lb below 2021, implying more runway than PE. - The bear case management concedes: demand destruction if oil/prices stay elevated. Their rebuttal — the bulk of PE goes into non-discretionary packaging/consumables, which held up even in 2008–09 and 2021.

Listen for: any July/current-quarter pricing data points (are increases sticking or rolling over?), commentary on the conflict's status, and whether Chinese/Asian operating rates are staying depressed. This is what moves the stock, not the Q2 headline.

Balance sheet & capital allocation — watch the dividend and the buyback question

Capital discipline has been the other big theme, and it's a source of tension: - The Board cut the quarterly dividend ~50% in Q1 2026 to defend the investment-grade rating (Q1 dividends paid ~$224M vs. $445M in Q2 2025). The new payout implies roughly a ~4–5% yield at current prices. - Cash Improvement Plan: targeting $500M incremental in 2026 (~$1.3B cumulative since 2025); trade working capital was down ~$450M y/y in Q1. - Liquidity: $2.6B cash / $7.3B available at end of Q1; 2026 and 2027 maturities were pre-funded in 2025. - Headcount down ~3,000 (~15%) since end-2024; fixed costs down >$50M y/y in Q1. - 2026 capex guided to ~$1.2B; MoReTec-1 (chemical recycling) ramps late 2027; growth pipeline pegged at ~+$400M EBITDA.

The key capital-allocation question for the call: with cash now surging, will management restore the dividend, restart buybacks (repurchases were paused/minimal), or accelerate the shelved growth projects (Flex-2, MoReTec-2, Middle East expansion)? CFO commentary was cautious — "only when the balance sheet and outlook is more secure." Any shift toward returning the windfall to shareholders vs. hoarding it would be a notable signal. Also watch for an intentional working-capital build in Q2 (flagged in Q1), which will temper free cash flow even as EBITDA jumps.

Key risks / what could go wrong

Ceasefire / conflict resolution unwinds the price premium faster than LYB expects (the consultants' base case for H2).
Demand destruction in durables (autos, building & construction remain soft) if prices/oil stay high.
Feedstock volatility — European butane near record highs vs. crude has been compressing oxyfuels margins; naphtha swings can whipsaw European crackers (partly why EAI is only running ~80%).
Bayport outage and La Porte limitations cap I&D this quarter.
APS margin lag from contractual repricing.
Structurally weak Technology/licensing as Chinese capex stalls.

Bottom line — what to watch tomorrow

The magnitude of the sequential EBITDA ramp off Q1's $615M, and how close O&P-Americas gets toward its 2021-era earning power.
PE/PP price realization — did the ~$0.50/lb of hikes actually settle, and are July prices holding?
Management's durability narrative vs. the consultant fade thesis — the most important driver of the stock given how much the price already round-tripped.
Capital-allocation signal — with cash building, any hint on dividend restoration, buybacks, or unlocking the growth pipeline.
Q3 setup — Bayport restart, European portfolio now streamlined, and whether the supply gap is still widening.

Net: this should be a strong quarter on paper, but with the stock having already surged and retreated, the market's reaction will hinge on whether LYB can convince investors the earnings power is structural rather than a transient war spike — and on how it plans to deploy the cash windfall.

Note: figures above are drawn from LYB's Q4 2025 / Q2 2025 releases, the Q1 2026 earnings call, and market prices through July 30, 2026. I did not have a published Street consensus for Q2 2026 in my sources, so expectations here are framed off the recent quarterly trajectory and management's own guidance rather than a formal consensus estimate.